Fiche centre
TG Therapeutics Investigational Trial Site
Tbilisi — Georgia
Essais liés2clinical trials
VilleTbilisilocalisation
PaysGeorgialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07211633
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Ublituximab | SEP | Phase 3 | NCT04130997 | An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis | ACTIVE_NOT_RECRUITING |
| Ublituximab | SEP | Phase 3 | NCT07211633 | A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS) | ACTIVE_NOT_RECRUITING |